ORIS:NASDAQOriental Rise Holdings Limited Analysis
Data as of 2026-05-19 - not real-time
$0.41
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Technical outlook: The 20‑day SMA (0.455) sits below the current price (0.410) while the 50‑day (0.566) and 200‑day (1.848) SMAs are far higher, indicating a bearish price gap. RSI at 40 suggests neutral‑to‑slightly‑oversold conditions, and the MACD line is marginally above its signal (bullish signal) but the histogram is tiny (0.013), offering little momentum. Support sits near $0.302 and resistance near $0.630, yet the price is trading just above support with a decreasing volume trend and a 30‑day volatility of 148%, flagging fragile price stability. Fundamentals: Valuation multiples are extremely low (PE ≈ 1.2, PB ≈ 0.006) but margins are negative (operating margin ‑15%) and cash flow is deeply negative (free cash flow ‑$2.3 M). The company’s max drawdown of ‑98% and a market cap of only $2.07 M underscore severe financial distress.
Material news: Nasdaq issued a delisting determination on April 15 2026 after the bid price stayed below $1.00, and the firm is ineligible for a 180‑day grace period due to a prior 1‑for‑20 reverse split. This regulatory blow, combined with the bearish technical setup and deteriorating liquidity, makes the stock highly speculative despite its seemingly cheap price.
Material news: Nasdaq issued a delisting determination on April 15 2026 after the bid price stayed below $1.00, and the firm is ineligible for a 180‑day grace period due to a prior 1‑for‑20 reverse split. This regulatory blow, combined with the bearish technical setup and deteriorating liquidity, makes the stock highly speculative despite its seemingly cheap price.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Nasdaq delisting determination
- Price hovering just above technical support
- Decreasing volume and extreme short‑term volatility
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Negative operating and free cash flow
- Continued regulatory uncertainty
- Lack of credible turnaround catalyst
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Structural financial weakness and near‑zero margins
- Potential for permanent delisting and loss of marketability
- Unclear path to sustainable earnings growth
Key Metrics & Analysis
Financial Health
Revenue Growth-1.30%
Profit Margin5.57%
P/E Ratio1.2
ROE0.92%
ROA-0.74%
Debt/Equity0.42
P/B Ratio0.0
Op. Cash Flow$-583000
Free Cash Flow$-2323125
Technical Analysis
TrendBearish
RSI40.1
Support$0.30
Resistance$0.63
MA 20$0.46
MA 50$0.57
MA 200$1.85
MACDBullish
VolumeDecreasing
Fear & Greed Index89.13
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.99
Volatility147.94%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.